Activated TAZ Induces Liver Cancer in Collaboration with EGFR/HER2 Signaling Pathways
Hyuk Moon(Kyung Hee University), Simon Weonsang Ro(Kyung Hee University)
Cited by 1
Related Papers
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
|International Journal of Molecular Sciences|2019|55
Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
|PLoS ONE|2013|52
Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
|BMC Gastroenterology|2016|20
Comparison of liver oncogenic potential among human RAS isoforms
|Oncotarget|2016|13